22 §1065. Influenza immunizing agent distribution report
Title 22: HEALTH AND WELFARE
Subtitle 2: HEALTH
Part 3: PUBLIC HEALTH HEADING: PL 1989, C. 487, §11 (RPR)
Chapter 251: COMMUNICABLE DISEASES HEADING: PL 1989, C. 487, §11 (RPR)
Subchapter 2-A: IMMUNIZATION
§1065. Influenza immunizing agent distribution report
A manufacturer or distributor that ships or distributes influenza immunizing agents to or within this State shall report information on the distribution of such agents to the Maine Center for Disease Control and Prevention as provided in this section. [2005, c. 628, §1 (NEW).]
1. Report timing and content. A manufacturer or distributor shall report the following information on the distribution of influenza immunizing agents in this State every 2 weeks during influenza season and on a monthly basis thereafter:
A. Contact name, company name, address, phone number and e-mail address of the manufacturer or distributor that is shipping or distributing influenza immunizing agents; [2005, c. 628, §1 (NEW).]
B. Contact name, business name, type of provider, address, phone number and e-mail address of the licensed health care provider or facility that will receive influenza immunizing agents; [2005, c. 628, §1 (NEW).]
C. The date that the manufacturer or distributor ships or distributes influenza immunizing agents and date that the delivery is received by the licensed health care provider or facility that ordered influenza immunizing agents; and [2005, c. 628, §1 (NEW).]
D. The type, quantity and dosage of influenza immunizing agents distributed to the licensed health care provider or facility. [2005, c. 628, §1 (NEW).]
[ 2005, c. 628, §1 (NEW) .]
2. Supply and demand. The department shall estimate the supply and demand for influenza immunizing agents at the beginning of each influenza season by assessing aggregate orders; reviewing information disseminated by manufacturers, distributors and the United States Department of Health and Human Services, Centers for Disease Control and Prevention; identifying the number and location of high priority populations; identifying possible geographic and provider type disparities; and reviewing historical demand patterns.
[ 2005, c. 628, §1 (NEW) .]
3. Confidentiality. Information obtained by the department under this section is confidential and may not be disclosed by the department except that the department may provide information obtained under this section to a licensed health care provider or facility located in the State in order to facilitate access to influenza immunizing agents for patients of that licensed health care provider or facility that are residents of the State.
[ 2005, c. 628, §1 (NEW) .]
4. Rules. The department shall adopt rules to implement this section. Rules adopted pursuant to this subsection are routine technical rules as defined in Title 5, chapter 375, subchapter 2-A.
[ 2005, c. 628, §1 (NEW) .]
SECTION HISTORY
2005, c. 628, §1 (NEW).